News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Ratcliffe Liam
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Granted 7,136 options to buy
@ $45.69, valued at
$326k
|
|
| 01/03/2023 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Granted 7,000 options to buy
@ $13.5, valued at
$94.5k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on Eliem Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.46, valued at
$34.6k
|
|
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2021 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS, INC.|
Txns:
| Sold 1,852 shares
@ $90.18, valued at
$167k
Sold 1,498 shares
@ $89.1588, valued at
$133.6k
Sold 5,853 shares
@ $88.1189, valued at
$515.8k
Sold 3,956 shares
@ $87.1143, valued at
$344.6k
Sold 199 shares
@ $86.5861, valued at
$17.2k
Sold 5,582 shares
@ $87.7089, valued at
$489.6k
Sold 18,007 shares
@ $86.3813, valued at
$1.6M
Sold 36,210 shares
@ $85.9247, valued at
$3.1M
Sold 17,449 shares
@ $85.9583, valued at
$1.5M
Sold 9,660 shares
@ $84.3141, valued at
$814.5k
Sold 12,760 shares
@ $84.0204, valued at
$1.1M
|
|
| 11/09/2021 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS, INC.|
Txns:
| Sold 6,423 shares
@ $91.5, valued at
$587.7k
Sold 7,060 shares
@ $91.5, valued at
$646k
Sold 4,940 shares
@ $90.75, valued at
$448.3k
Sold 5,221 shares
@ $91.59, valued at
$478.2k
Sold 795 shares
@ $90.29, valued at
$71.8k
Sold 484 shares
@ $89.65, valued at
$43.4k
Sold 4,519 shares
@ $94.0775, valued at
$425.1k
Sold 1,825 shares
@ $93.033, valued at
$169.8k
Sold 15,327 shares
@ $91.8147, valued at
$1.4M
Sold 8,676 shares
@ $91.0904, valued at
$790.3k
Sold 2,747 shares
@ $89.863, valued at
$246.9k
|
|
| 08/11/2021 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on Eliem Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $12.5, valued at
$250k
|
|
| 06/10/2021 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS, INC.|
Txns:
| Granted 7,511 options to buy
@ $78.53, valued at
$589.8k
|
|
| 05/28/2021 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 16,918 options to buy
@ $13.83, valued at
$234k
|
|
| 12/21/2020 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS, INC.|
Txns:
| Bought 142,857 shares
@ $70, valued at
$10M
|
|
| 06/04/2020 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS, INC.|
Txns:
| Granted 12,000 options to buy
@ $33.57, valued at
$402.8k
|
|
| 05/27/2020 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS, INC.|
Txns:
| Exercised 6,500 options to buy
@ $22.06, valued at
$143.4k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2019 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS, INC.|
Txns:
| Bought 680,000 shares
@ $22, valued at
$15M
|
|
| 06/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2019 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS, INC.|
Txns:
| Granted 12,923 options to buy
@ $22.06, valued at
$285.1k
|
|
| 04/03/2019 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 4,829 options to buy
@ $4.4, valued at
$21.2k
|
|
| 04/02/2019 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 4,123 options to buy
@ $4.05, valued at
$16.7k
|
|
| 03/18/2019 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Exercised 10,000 restricted stock units
@ $0 |
|
| 01/04/2019 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 4,860 options to buy
@ $4.47, valued at
$21.7k
|
|
| 10/03/2018 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS INC.|
Txns:
| Converted 1,108,202 shares
@ $0
Converted 174,846 shares
@ $0
Bought 625,000 shares
@ $16, valued at
$10M
Bought 375,000 shares
@ $16, valued at
$6M
Converted 3,601,657 preferred shares
@ $0
Converted 568,252 preferred shares
@ $0 |
|
| 10/03/2018 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 2,111 options to buy
@ $10.37, valued at
$21.9k
|
|
| 09/26/2018 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 1,504 options to buy
@ $14.57, valued at
$21.9k
|
|
| 08/15/2018 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Granted 10,000 restricted stock units
@ $0 |
|
| 06/26/2018 |
4
| Ratcliffe Liam (10% Owner) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Converted 1,047,450 shares
@ $0
Converted 1,197,076 shares
@ $0
Converted 552,208 shares
@ $0
Converted 243,345 shares
@ $0
Bought 125,000 shares
@ $16, valued at
$2M
Bought 125,000 shares
@ $16, valued at
$2M
Converted 28,895,188 convertible preferred
@ $0
Converted 33,022,786 convertible preferred
@ $0
Converted 15,233,315 convertible preferred
@ $0
Converted 6,712,986 convertible preferred
@ $0 |
|
| 06/20/2018 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on Edge Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.1, valued at
$22k
|
|
| 05/31/2018 |
4
| Lathi Vijay K (10% Owner) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Converted 466,793 shares
@ $0
Converted 178,230 shares
@ $0
Converted 148,603 shares
@ $0
Bought 278,062 shares
@ $13, valued at
$3.6M
Bought 384,615 shares
@ $13, valued at
$5M
Converted 466,793 options to buy
@ $0
Converted 178,230 options to buy
@ $0
Converted 148,603 options to buy
@ $0 |
|
| 05/21/2018 |
4
| Ratcliffe Liam (10% Owner) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 12,000 options to buy
@ $25.73, valued at
$308.8k
|
|
| 04/03/2018 |
4
| Ratcliffe Liam (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Converted 622,772 shares
@ $0
Converted 622,773 shares
@ $0
Bought 275,000 shares
@ $12, valued at
$3.3M
Bought 275,000 shares
@ $12, valued at
$3.3M
Converted 977,835 preferred shares
@ $0
Converted 977,836 preferred shares
@ $0 |
|
| 10/02/2017 |
4
| Ratcliffe Liam (10% Owner) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Converted 839,110 shares
@ $0
Converted 1,118,722 shares
@ $0
Converted 279,703 shares
@ $0
Converted 1,118,722 shares
@ $0
Converted 372,883 shares
@ $0
Bought 375,000 shares
@ $17, valued at
$6.4M
Converted 148,515 preferred shares
@ $0
Converted 198,004 preferred shares
@ $0
Converted 49,505 preferred shares
@ $0
Converted 198,004 preferred shares
@ $0
Converted 65,997 preferred shares
@ $0 |
|
| 06/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/25/2016 |
4
| New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on iRhythm Technologies, Inc.|
Txns:
| Converted 1,716,589 shares
@ $0
Bought 25,000 shares
@ $17, valued at
$425k
Converted 610,136 convertible preferred
@ $0
Converted 190,154 convertible preferred
@ $0
Converted 155,548 convertible preferred
@ $0
Converted 72,389 options to buy
@ $0.001, valued at
$72.4 |
|
|
|
|